230 related articles for article (PubMed ID: 19342211)
1. Antigen presentation in celiac disease.
Qiao SW; Sollid LM; Blumberg RS
Curr Opin Immunol; 2009 Feb; 21(1):111-7. PubMed ID: 19342211
[TBL] [Abstract][Full Text] [Related]
2. Plasma Cells Are the Most Abundant Gluten Peptide MHC-expressing Cells in Inflamed Intestinal Tissues From Patients With Celiac Disease.
Høydahl LS; Richter L; Frick R; Snir O; Gunnarsen KS; Landsverk OJB; Iversen R; Jeliazkov JR; Gray JJ; Bergseng E; Foss S; Qiao SW; Lundin KEA; Jahnsen J; Jahnsen FL; Sandlie I; Sollid LM; Løset GÅ
Gastroenterology; 2019 Apr; 156(5):1428-1439.e10. PubMed ID: 30593798
[TBL] [Abstract][Full Text] [Related]
3. Single-chain recombinant HLA-DQ2.5/peptide molecules block α2-gliadin-specific pathogenic CD4+ T-cell proliferation and attenuate production of inflammatory cytokines: a potential therapy for celiac disease.
Huan J; Meza-Romero R; Mooney JL; Vandenbark AA; Offner H; Burrows GG
Mucosal Immunol; 2011 Jan; 4(1):112-20. PubMed ID: 20736999
[TBL] [Abstract][Full Text] [Related]
4. Gluten: a two-edged sword. Immunopathogenesis of celiac disease.
Koning F; Gilissen L; Wijmenga C
Springer Semin Immunopathol; 2005 Sep; 27(2):217-32. PubMed ID: 16091925
[TBL] [Abstract][Full Text] [Related]
5. Pathomechanisms in celiac disease.
Dieterich W; Esslinger B; Schuppan D
Int Arch Allergy Immunol; 2003 Oct; 132(2):98-108. PubMed ID: 14600421
[TBL] [Abstract][Full Text] [Related]
6. Celiac disease: how complicated can it get?
Tjon JM; van Bergen J; Koning F
Immunogenetics; 2010 Oct; 62(10):641-51. PubMed ID: 20661732
[TBL] [Abstract][Full Text] [Related]
7. High abundance of plasma cells secreting transglutaminase 2-specific IgA autoantibodies with limited somatic hypermutation in celiac disease intestinal lesions.
Di Niro R; Mesin L; Zheng NY; Stamnaes J; Morrissey M; Lee JH; Huang M; Iversen R; du Pré MF; Qiao SW; Lundin KE; Wilson PC; Sollid LM
Nat Med; 2012 Feb; 18(3):441-5. PubMed ID: 22366952
[TBL] [Abstract][Full Text] [Related]
8. Large-scale characterization of natural ligands explains the unique gluten-binding properties of HLA-DQ2.
Stepniak D; Wiesner M; de Ru AH; Moustakas AK; Drijfhout JW; Papadopoulos GK; van Veelen PA; Koning F
J Immunol; 2008 Mar; 180(5):3268-78. PubMed ID: 18292551
[TBL] [Abstract][Full Text] [Related]
9. Structure of celiac disease-associated HLA-DQ8 and non-associated HLA-DQ9 alleles in complex with two disease-specific epitopes.
Moustakas AK; van de Wal Y; Routsias J; Kooy YM; van Veelen P; Drijfhout JW; Koning F; Papadopoulos GK
Int Immunol; 2000 Aug; 12(8):1157-66. PubMed ID: 10917890
[TBL] [Abstract][Full Text] [Related]
10. The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase.
Arentz-Hansen H; Körner R; Molberg O; Quarsten H; Vader W; Kooy YM; Lundin KE; Koning F; Roepstorff P; Sollid LM; McAdam SN
J Exp Med; 2000 Feb; 191(4):603-12. PubMed ID: 10684852
[TBL] [Abstract][Full Text] [Related]
11. Local communication among mucosal immune cells in patients with celiac disease.
van Bergen J; Mulder CJ; Mearin ML; Koning F
Gastroenterology; 2015 May; 148(6):1187-94. PubMed ID: 25623043
[TBL] [Abstract][Full Text] [Related]
12. The preferred substrates for transglutaminase 2 in a complex wheat gluten digest are Peptide fragments harboring celiac disease T-cell epitopes.
Dørum S; Arntzen MØ; Qiao SW; Holm A; Koehler CJ; Thiede B; Sollid LM; Fleckenstein B
PLoS One; 2010 Nov; 5(11):e14056. PubMed ID: 21124911
[TBL] [Abstract][Full Text] [Related]
13. Antigen presentation to celiac lesion-derived T cells of a 33-mer gliadin peptide naturally formed by gastrointestinal digestion.
Qiao SW; Bergseng E; Molberg Ø; Xia J; Fleckenstein B; Khosla C; Sollid LM
J Immunol; 2004 Aug; 173(3):1757-62. PubMed ID: 15265905
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the binding of gluten T-cell epitopes to various human leukocyte antigen class II molecules.
Bergseng E; Sidney J; Sette A; Sollid LM
Hum Immunol; 2008 Feb; 69(2):94-100. PubMed ID: 18361933
[TBL] [Abstract][Full Text] [Related]
15. Biomedicine. Gluten and the gut-lessons for immune regulation.
Schuppan D; Hahn EG
Science; 2002 Sep; 297(5590):2218-20. PubMed ID: 12351776
[No Abstract] [Full Text] [Related]
16. Celiac disease as a model of gastrointestinal inflammation.
Sollid LM
J Pediatr Gastroenterol Nutr; 2005 Apr; 40 Suppl 1():S41-2. PubMed ID: 15805849
[No Abstract] [Full Text] [Related]
17. Differences in the risk of celiac disease associated with HLA-DQ2.5 or HLA-DQ2.2 are related to sustained gluten antigen presentation.
Fallang LE; Bergseng E; Hotta K; Berg-Larsen A; Kim CY; Sollid LM
Nat Immunol; 2009 Oct; 10(10):1096-101. PubMed ID: 19718029
[TBL] [Abstract][Full Text] [Related]
18. Genes and environment in celiac disease.
Sollid LM; McAdam SN; Molberg O; Quarsten H; Arentz-Hansen H; Louka AS; Lundin KE
Acta Odontol Scand; 2001 Jun; 59(3):183-6. PubMed ID: 11501889
[TBL] [Abstract][Full Text] [Related]
19. Evidence that HLA-DQ9 confers risk to celiac disease by presence of DQ9-restricted gluten-specific T cells.
Bodd M; Tollefsen S; Bergseng E; Lundin KE; Sollid LM
Hum Immunol; 2012 Apr; 73(4):376-81. PubMed ID: 22342873
[TBL] [Abstract][Full Text] [Related]
20. Two novel HLA-DQ2.5-restricted gluten T cell epitopes in the DQ2.5-glia-γ4 epitope family.
Qiao SW; Sollid LM
Immunogenetics; 2019 Nov; 71(10):665-667. PubMed ID: 31673720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
